Composition
- Active ingredients
- STAVUDINE 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- STAVUDINE 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · For solutionNDA020413-001 · Discontinued
- STAVUDINE 5MG · CapsuleNDA020412-001 · Discontinued
- STAVUDINE 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleThis page
- STAVUDINE 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA020412-002 · Discontinued
- STAVUDINE 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA020412-005 · Discontinued
- STAVUDINE 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA020412-003 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020412.
At a glance
- Brand name
- Zerit
- Active substance
- stavudine
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Bristol
- Status
- Discontinued
- FDA approval
- 24 Jun 1994
- Application
- NDA020412-004